NYSE : RVTY
Revvity, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 165.78 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 18.50B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 16.92B |
| Enterprise Value | 19.24B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Oct 23, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 111.59M |
| Shares Outstanding | 111.59M |
| Shares Change (YoY) | -6.21% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 0.41% |
| Owned by Institutions (%) | 95.57% |
| Float | 102.49M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 72.37 |
| Forward PE | 26.88 |
| PS Ratio | 5.82 |
| Forward PS | 5.80 |
| PB Ratio | 2.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 30.37 |
| P/OCF Ratio | 27.01 |
| PEG Ratio | 2.72 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 81.12 |
| EV / Sales | 6.62 |
| EV / EBITDA | 22.00 |
| EV / EBIT | 41.57 |
| EV / FCF | 34.53 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.80 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 3.60 |
| Debt / FCF | 5.99 |
| Interest Coverage | 4.93 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 3.21% |
| Return on Assets (ROA) | 2.37% |
| Return on Invested Capital (ROIC) | 4.39% |
| Return on Capital Employed (ROCE) | 4.30% |
| Weighted Average Cost of Capital (WACC) | 8.86% |
| Revenue Per Employee | $264,710 |
| Profits Per Employee | $21,596 |
| Employee Count | 11,000 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 3.42 |
Taxes
| Measure | Value |
|---|
| Income Tax | 23.40M |
| Effective Tax Rate | 8.97% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +61.98% |
| 50-Day Moving Average | 145.02 |
| 200-Day Moving Average | 112.06 |
| Relative Strength Index (RSI) | 47.37 |
| Average Volume (20 Days) | 1,785,159 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 6.39M |
| Short Previous Month | 6.22M |
| Short % of Shares Out | 5.73% |
| Short % of Float | 6.24% |
| Short Ratio (days to cover) | 2.82 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.91B |
| Gross Profit | 1.60B |
| Operating Income | 463.60M |
| Pretax Income | 260.77M |
| Net Income | 237.55M |
| EBITDA | 875.83M |
| EBIT | 463.60M |
| Earnings Per Share (EPS) | $2.09 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 3.34B |
| Net Cash | -2.32B |
| Net Cash Per Share | -$20.78 |
| Equity (Book Value) | 7.23B |
| Book Value Per Share | 64.78 |
| Working Capital | 1.02B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 627.63M |
| Capital Expenditures | -69.52M |
| Depreciation & Amortization | 412.24M |
| Net Borrowing | -418,000 |
| Free Cash Flow | 558.11M |
| FCF Per Share | $5.00 |
Margins
| Measure | Value |
|---|
| Gross Margin | 54.98% |
| Operating Margin | 15.92% |
| Pretax Margin | 8.96% |
| Profit Margin | 8.16% |
| EBITDA Margin | 30.08% |
| EBIT Margin | 15.92% |
| FCF Margin | 19.17% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.28 |
| Dividend Yield | 0.18% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 13.37% |
| FCF Payout Ratio | 5.60% |
| Buyback Yield | 6.21% |
| Shareholder Yield | 6.40% |
| Earnings Yield | 1.38% |
| FCF Yield | 3.29% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $147.53 |
| Price Target Difference | -2.68% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | 3.81% |
| EPS Growth Forecast (3Y) | 8.76% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 4, 2001 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.54 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |